scholarly journals Futuristic Developments and Applications in Endoluminal Stenting

2022 ◽  
Vol 2022 ◽  
pp. 1-13
Author(s):  
Joel Ferreira-Silva ◽  
Renato Medas ◽  
Mohit Girotra ◽  
Monique Barakat ◽  
James H. Tabibian ◽  
...  

Endoscopic stenting is a well-established option for the treatment of malignant obstruction, temporary management of benign strictures, and sealing transmural defects, as well as drainage of pancreatic fluid collections and biliary obstruction. In recent years, in addition to expansion in indications for endoscopic stenting, considerable strides have been made in stent technology, and several types of devices with advanced designs and materials are continuously being developed. In this review, we discuss the important developments in stent designs and novel indications for endoluminal and transluminal stenting. Our discussion specifically focuses on (i) biodegradable as well as (ii) irradiating and drug-eluting stents for esophageal, gastroduodenal, biliary, and colonic indications, (iii) endoscopic stenting in inflammatory bowel disease, and (iv) lumen-apposing metal stent.

2019 ◽  
Vol 156 (6) ◽  
pp. S-1043
Author(s):  
Osman Ahmed ◽  
Phonthep Angsuwatcharakon ◽  
Brian R. Weston ◽  
Phillip Lum ◽  
William A. Ross ◽  
...  

Author(s):  
Babatunde Olaiya ◽  
Parit Mekaroonkamol ◽  
Bai-Wen Li ◽  
Julia Massaad ◽  
Cicily T Vachaparambil ◽  
...  

Abstract Background Fluoroscopy is often used during the endoscopic drainage of pancreatic-fluid collections (PFCs). An electrocautery-enhanced coaxial lumen-apposing, self-expanding metal stent (ELAMS) facilitates a single-step procedure and may avoid the need for fluoroscopy. This study compares the treatment outcomes using ELAMS with and without fluoroscopy. Methods Patients with PFCs who had cystogastrostomy from January 2014 to February 2017 were enrolled. Two groups were studied based on fluoroscopy use. Technical success was defined as uneventful insertion of ELAMS at time of procedure. Clinical success was defined as (i) clinical resolution of symptoms after the procedure and (ii) >75% reduction in cyst size on computed tomography 8 weeks after stent placement. Adverse events including bleeding, stent migration, and infection were recorded. Results A total of 21 patients (13 males) had PFCs drainage with ELAMS in the study period. The mean age was 51.6 ± 14.2 years. Thirteen patients had walled-off necrosis while eight had a pancreatic pseudocyst. The mean size of the PFCs was 11.3 ± 3.3 cm. Fluoroscopy was used in seven cases (33%) and was associated with a longer procedure time compared to non-fluoroscopy (43.1 ± 10.4 vs 33.3 ± 10.5 min, P = 0.025). This association was independent of the size, location, or type of PFCs. Fluoroscopy had no effect on the technical success rates. In fluoroless procedures, the clinical resolution was 91% as compared to 71% in fluoroscopy procedures (P = 0.52) and the radiologic resolution was 57% as compared to 71% in fluoroscopy procedures (P = 0. 65). Three cases of stent migration/displacement occurred in the fluoroless procedures. Conclusions ELAMS may avoid the need for fluoroscopy during cystogastrostomy. Procedures without fluoroscopy were significantly shorter and fluoroscopy use had no impact on the technical or clinical success rates.


Pancreatology ◽  
2014 ◽  
Vol 14 (3) ◽  
pp. S33
Author(s):  
Matthew Huggett ◽  
Kofi Oppong ◽  
Stephen Pereira ◽  
Vikram Mitra ◽  
Richard Charnley ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document